Overview
Harry Fuentes is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Fuentes is rated as an Experienced provider by MediFind in the treatment of Acute Promyelocytic Leukemia. His top areas of expertise are Epithelial-Myoepithelial Carcinoma, Polymorphous Low Grade Adenocarcinoma, Adenoid Cystic Carcinoma, and Acinic Cell Carcinoma of Salivary Glands.
His clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- INDEMNITY
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 1st St Sw, Rochester, MN 55905
Additional Areas of Focus
Dr. Fuentes has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Mark Litzow is a Hematologist and a Hematologist Oncology provider in Rochester, Minnesota. Dr. Litzow is rated as an Elite provider by MediFind in the treatment of Acute Promyelocytic Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Graft. Dr. Litzow is currently accepting new patients.
Mayo Clinic
Naseema Gangat is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Gangat is rated as an Elite provider by MediFind in the treatment of Acute Promyelocytic Leukemia. Her top areas of expertise are Myelofibrosis, Leukocytosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Splenectomy. Dr. Gangat is currently accepting new patients.
Michelle Elliott is a Hematologist in Rochester, Minnesota. Dr. Elliott is rated as a Distinguished provider by MediFind in the treatment of Acute Promyelocytic Leukemia. Her top areas of expertise are Chronic Myelomonocytic Leukemia (CMML), Leukemia, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Elliott is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Fuentes isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Promyelocytic LeukemiaDr. Fuentes isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adenoid Cystic CarcinomaDr. Fuentes isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Fuentes isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Fuentes isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Fuentes isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.